Search results for CXCL5 antibody

CXCL5 antibody, Genetex, GTX29983

CXCL5 Antibody (YA3504), MedChemexpress, HY-P81179

CXCL5 Antibody (YA3504) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to CXCL5.

CXCL5 antibody [10L19], Genetex, GTX52669

CXCL5 antibody [32B3], Genetex, GTX53165

CXCL5 antibody [4F47], Genetex, GTX53373

Anti-CXCL5 antibody, Abcam, AB18134

Mouse CXCL5 is the equivalent of human CXCL6 based on genetic and biological evidence as pointed out by Nomiyama et al. (PMID: 20434943).

Anti-CXCL5 antibody, Abcam, AB9802

Although some customers have been successful in IHC we no longer batch test in this application.

Anti-CXCL5 antibody [RP23040004], Abcam, AB308023

What are recombinant multiclonals? Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including: - The sensitivity of polyclonal antibodies by recognising multiple epitopes - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production View our range of recombinant multiclonal antibodies .

Anti-CXCL5 antibody [EPR23928-217], Abcam, AB305100

What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents .

Anti-CXCL5 antibody [EPR4450(2)], Abcam, AB126763

Species reactivity Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .